Nanobody Lab

Research interests

  • Use of nanobodies to manipulate (intracellular) protein function, given that pharmacological inhibitors are wanting for the majority of polypeptides.
  • Target proteins are involved in cancer, signal transduction or amyloid disorders
  • Improvement of nanobody technology by converting nanobodies into a specificity key charged with a payload (antibody drug conjugate) by incorporating non-standard amino acids 

Gulliver Biomed is a spin-off company from the Nanobody Lab.

More information about the Nanobody Lab

More information about Prof. Jan Gettemans

Prof. Jan Gettemans is member of